Featured Videos

Ask the AML Expert: What Do New Drugs Mean for My AML?

‘We’ve had years and years of research that we’ve been building upon to get to this point,’ says noted AML expert Dr. Daniel Pollyea. Watch this Ask the Expert replay to learn about advances for patients.

Published:

Relapses in CLL: Allaying Fears and Taking Action

This Partners program features expert Dr. Nitin Jain, CLL patients Carol Preston, James Miller and Andrew Schorr. Listen in as the panel focuses on remission duration, retreatment and fear of relapse.

Published:

CML News From ASH: Patient Advocate Perspective

As part of our coverage of the 2018 American Society of Hematology (ASH) annual meeting in San Diego, Jan Geissler, a patient advocate and director of the European Patients Academy on Therapeutic Innovation, joined Patient Power to share his perspective on the latest news in chronic myeloid leukemia (CML).

Published:

Genetic Subtypes for AML: How Does Mutational Status Influence Care?

How do genetic test results affect AML treatment decisions, and when is the best time for testing? Watch now to find out from leading expert Dr. Uma Borate.

Published:

CLL Patient Cafe: Managing Side Effects and Symptoms

Back pain, fatigue, night sweats, sinus infections. How do CLL patients deal with unpleasant and uncomfortable symptoms? Tune in as CLL patients discuss managing symptoms and side effects.

Published:

CML News at ASH 2018: Data From Treatment-Free Remission Studies

What's the latest news in CML treatment-free remission studies at ASH 2018? Watch as CML expert Dr. Michael Savona shares encouraging CML treatment and research developments.

Published:

Advertisement
tritt unserer Gemeinschaft bei Registrieren Sie sich für Veranstaltungen Lesen Sie unseren neuesten Blog
Advertisement

Page last updated on June 18, 2019